HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ruian Ke Selected Research

Ruian Ke Research Topics

Disease

18Infections
03/2024 - 04/2014
7COVID-19
04/2024 - 01/2021
3Virus Diseases (Viral Diseases)
04/2024 - 01/2021
2Viremia
10/2023 - 01/2021
2Breakthrough Infections
07/2022 - 09/2021
1Human Influenza (Influenza)
01/2023
1Inflammation (Inflammations)
01/2022
1Acquired Immunodeficiency Syndrome (AIDS)
01/2021
1Communicable Diseases (Infectious Diseases)
01/2021
1Fatigue
10/2016
1Fibrosis (Cirrhosis)
10/2016
1Headache (Headaches)
10/2016
1Chronic Hepatitis C
10/2016
1Coinfection
01/2012

Drug/Important Bio-Agent (IBA)

7Antiviral Agents (Antivirals)IBA
11/2022 - 10/2016
4AntigensIBA
02/2024 - 03/2021
3RNA (Ribonucleic Acid)IBA
01/2023 - 10/2016
2Monoclonal AntibodiesIBA
04/2024 - 09/2023
2bamlanivimabIBA
11/2022 - 09/2021
2COVID-19 VaccinesIBA
07/2022 - 09/2021
2Viral RNAIBA
01/2022 - 07/2021
2VaccinesIBA
01/2021 - 10/2017
2daclatasvirIBA
10/2016 - 04/2014
1CD4 Antigens (CD4 Antigen)IBA
03/2024
1VorinostatFDA Link
02/2024
1Interferon Type IIBA
01/2022
1Pathogen-Associated Molecular Pattern MoleculesIBA
01/2022
1InterferonsIBA
01/2021
1N,N'- (2,2'- (hexa- 2,4- diyne- 1,6- diylbis(oxy))bis(2,3- dihydro- 1H- indene- 2,1- diyl))bis(1- (2- cyclohexyl- 2- (2- (methylamino)propanamido)acetyl)pyrrolidine- 2- carboxamide)IBA
01/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2017
1sofosbuvir drug combination ledipasvirIBA
10/2016
1asunaprevirIBA
10/2016
1SofosbuvirIBA
10/2016
1SimeprevirIBA
10/2016
1NucleotidesIBA
10/2016
1Protease Inhibitors (Protease Inhibitor)IBA
10/2016
1Proteins (Proteins, Gene)FDA Link
04/2014

Therapy/Procedure

8Therapeutics
04/2024 - 01/2012
1Art Therapy
10/2023